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1015-9584/Copyright ª 2015, Asian SuSummary Objective: Laparoendoscopic single-site (LESS) adrenalectomy is a promising mini-
mally invasive technique, however, the current evidence has not confirmed its long-term
effectiveness in primary aldosteronism (PA). We conducted a study to analyze the long-term
efficacy of LESS adrenalectomy in patients with PA.
Methods: A total of 49 patients who had been clinically confirmed with PA who had an indica-
tion for unilateral adrenalectomy were included in this study. Perioperative data were ob-
tained for all patients. Blood pressure and the levels of serum aldosterone, renin, and
potassium were checked periodically. The median follow-up was 16.5 months.
Results: No intra- or early post-operative complication occurred. All LESS adrenalectomies
were completed successfully, except one with laparoscopic conversion. Hypokalemia was
resolved in all cases and no patient required potassium supplements after surgery. Post-oper-
ative cure of hypertension was achieved in 63% of our patients. Overall, 84% of our PA patients
had clinical improvement in blood pressure control after surgery.ng authors declare no conflicts of interest.
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j.asjsur.2015.09.002Conclusions: Our long-term experience revealed that LESS adrenalectomy is a safe and effec-
tive approach, which demonstrated comparable long-term cure and improvement of hyperten-
sion to a conventional laparoscopic series in treating PA.
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reserved.Table 1 Patient characteristics and surgical results.
No. of patients 49
Age (y) 50.8 (11.5)
Sex (M:F) 28/21
BMI 27.8 (7.2)
Operative time (min) 112.7 (52.3)
Specimen weight (g) 18.6 (9.3)
Right/left side tumor 22/27
Histopathology
Adrenocortical adenoma (APA) 47
Nodular adrenal hyperplasia 1
Hyperplasia (IHA) 1
Median follow up (mo), (range) 16.5 (3e60)
No. lost to follow up (%) 3 (6.1)
Data expressed as mean (SD) or absolute number of patients.
APA Z aldosterone-secreting adenomas; BMI Z body mass
index; F Z female; IHA Z idiopathic hyperaldosteronism;
M Z male; SD Z standard deviation.1. Introduction
Primary aldosteronism (PA) is one of the few surgically
curable causes of hypertension. PA is usually caused by
aldosterone-secreting adenomas (APA) in the unilateral or
bilateral adrenal gland, however, it may also be caused by
small hyperplastic or multiple nodular lesions. According to
a screening study in Japan, PA is found in 3.3e10% of hy-
pertensive patients and is the most common cause of sec-
ondary hypertension.1e3 To date, unilateral adrenalectomy
is still the treatment of choice in patients with APA and
unilateral hyperplasia.
Laparoscopic adrenalectomy has become the recom-
mended procedure for unilateral APA or hyperplasia due to
less postoperative pain and shorter convalescence when
compared with its open surgery counterpart.4,5 A recent
revolution in surgery, the laparoendoscopic single-site
surgery (LESS), has been widely implemented in various
surgical indications including adrenalectomy.6e13 Pre-
liminary results have revealed comparable safety and ef-
ficacy in removing benign adrenal lesions to the
conventional laparoscopic approach, but with additional
clinical benefits of less postoperative pain, and a shorter
hospital stay.14,15
Among a larger series of LESS adrenalectomies, APA is
the most common surgical indication, comprising up to 50%
of all cases.11,16e18 However, as a promising and emerging
minimally invasive technique, the current evidence has not
confirmed its long-term effectiveness in this most common
surgical indication. Therefore, we conducted a study to
analyze the long-term efficacy of LESS adrenalectomy in
patients with PA.
2. Materials and methods
2.1. Patients
We maintain a prospective database of all LESS performed
in our department, including LESS adrenalectomy since
January 2007. This study is a retrospective review of pro-
spectively collected data from this database.
Between October 2009 and October 2014, 105 LESS ad-
renalectomies were performed by a single surgeon (YCT)
who is experienced in laparoscopic adrenalectomy. We
shifted our adrenalectomy to the LESS approach in 2009,
except in cases with a tumor size >6 cm where the risk of
malignancy is high, or cases with a body mass index (BMI) >
45 because of difficulty in maintaining pneumoperitoneum
under a single port design. Based on this database, we
identified 49 patients who had been clinically confirmed (by: Hu Y-H, et al., Laparoendosc
y with long-term follow up,saline infusion and captopril tests) to have PA to be
included in this study. Those PA patients who had incon-
clusive abdominal contrast-enhanced computed tomogra-
phy (CT) results underwent adrenal scintigraphy using 131I-
6 b-iodomethyl-19-norcholesterol (NP-59) SPECT/CT and/or
adrenal venous sampling (AVS) for lateralization. The
baseline characteristics of these 49 patients are listed in
Table 1.
2.2. Operative technique
After induction of general anesthesia, the patient was
placed in the prone jack-knife position. LESS adrenalec-
tomy starts with a 2.0e3.0-cm skin incision just beneath
the tip of the 12th rib. The subcutaneous tissues and fascia
were dissected sharply. Using blunt finger dissection, the
retroperitoneal space was created for the single-port
placement. A homemade or commercial single port was
placed in position through the incision.13 The capnore-
troperitoneum is created by a carbon dioxide pressure of
15e20 mmHg. After pneumoretroperitoneum was estab-
lished, a rigid 5-mm, 30 laparoscope and conventional 5-
mm laparoscopic instruments were used for subsequent
manipulation. Step-by-step, after creation of the retro-
peritoneal space by blunt dissection, the upper pole of the
kidney was mobilized. Dissection of the adrenal gland
started from medial side of the adrenal gland. For the right
adrenal tumors, the adrenal arteries which cross the venaopic single-site adrenalectomy in patients with primary hyper-
Asian Journal of Surgery (2015), http://dx.doi.org/10.1016/
Table 2 Perioperative outcomes and patient’s satisfac-
tion with surgery.
No. of patients
Conversion to conventional
laparoscopy (%)
1 (2)
Late postoperative complication
Chronic wound pain 1
Erectile dysfunction 2
Total (%) 3 (2)
Mean time to oral intake (day) 0.2 (0.2)
Mean hospital stay (d) 2.2 (.8)
Return to normal daily
activity (d), (mean)
3.9 (4.6)
Overall satisfaction with surgery
(on POD 7) (%)
Extremely satisfied 31 (63)
Satisfied 12 (25)
Average 5 (10)
Unsatisfied 1 (2)
Extremely unsatisfied 0
Data expressed as mean (SD) or absolute no. of patients unless
otherwise stated.
POD Z postoperative day; SD Z standard deviation.
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LigaSure V Sealer/Divider (Covidien, Valleylab, Boulder,
CO, USA). The short adrenal vein was then located,
controlled, and transected using LigaSure (Covidien). Then,
the right adrenal gland was completely mobilized by lateral
and cranial dissection. For the left-sided adrenalectomy,
dissection started from the inferior, medial border of the
adrenal gland which is just above the anatomic landmark of
the left renal artery. Then, the main left adrenal vein was
identified, controlled, and transected using LigaSure (Cov-
idien). After that, an extended mobilization of the upper
pole of the kidney was performed. Thereafter, the inferior
part of the gland could be identified and dissected. Both
adrenal glands with the surrounding fatty tissue were
removed in an en bloc manner and the completely mobi-
lized specimen was placed in a retrieval bag.
2.3. Follow up
The median follow up was 16.5 months. Most of the pa-
tients returned to the clinic for follow up, except three
patients who were lost to follow up after 3 months. Blood
pressure and the levels of serum aldosterone, renin, and
potassium were checked periodically. Postadrenalectomy
clinical outcomes were judged on the basis of improvement
of hypertension and hypokalemia. Hypertension was
considered cured if blood pressure decreased to 140/
90 mmHg shortly after adrenalectomy and antihypertensive
medications were not required during the 1st year after
adrenalectomy. Patients whose hypertension subsided
within the 1st year but later returned were still classified as
cured. Hypokalemia was considered resolved if serum
potassium levels remained normal without potassium
supplementation.
2.4. Statistical analysis
Summaries of continuous variables were calculated as the
mean  standard deviation. Continuous variables were
tested for normality using the ShapiroeWilk’s test. The
ManneWhitney U-test or the independent samples t-test
was used for continuous variables depending on the
normality of the variable. A p value < 0.05 was considered
statistically significant. The learning and cumulative curve
were generated with logarithmic regression model using
SPSS computer software. Statistical analyses were per-
formed using SPSS for Windows (Version 18.0, PASW, SPSS,
Inc., Chicago, IL, USA).
3. Results
The perioperative outcomes are summarized in Tables 1
and 2. No conversions to open adrenalectomy were
necessary and only one super-obese female patient (BMI
> 45) was converted to a conventional laparoscopic
approach due to inability to maintain a reasonable
retroperitoneal space during the LESS retroperitoneal
approach. The median operative time was 112.5 minutes
with a range from 35 minutes to 237 minutes. The
learning curve demonstrated in Figure 1 revealed a
short learning period, whereby most of the learningPlease cite this article in press as: Hu Y-H, et al., Laparoendosco
aldosteronism: A prospective study with long-term follow up,
j.asjsur.2015.09.002occurs in the first 15e20 cases. Our learning curve
became linear after the first 20 cases. The mean oper-
ative time revealed a significant reduction from
140.5  56.7 minutes to 93.4  40.9 minutes after the
learning period (first 20 cases; p < 0.0001; Figure 1).
The blood loss was minimal (<50 mL) in all cases. All
cases had his/her adrenal tumor removed en bloc with
its adrenal gland and had at least one main adrenal vein
identified.
No intraoperative or early postoperative complications
occurred. Three patients experienced late complications,
one experienced chronic wound pain after 6 months after
the operation and the other two experienced erectile
dysfunction up to 6 months of follow up, which was
improved by oral phosphodiesterase Type 5 inhibitors
(Table 2). The learning curve also impacted patients’
convalescence significantly. The time required for
resumption of oral intake revealed a significant improve-
ment after the learning period (0.3  0.3 days vs. 0.1  0.1
days; p < 0.0001; Figure 2) Improvement in convalescence
was also noted in the time to return normal activity with a
mean of 6.3  6.4 days during learning period and a mean
of 2.2  1.2 days after learning (p < 0.0001; Figure 3). The
majority of the patients (88%) were satisfied or extremely
satisfied with the surgical results (Table 2).
Postoperative cure of hypertension (29/46 patients;
normotensive without antihypertensive medication) or sig-
nificant improvement of hypertension (10/46 patients;
normotensive with less antihypertensive medication when
compared with preoperative status) was confirmed in 39/46
(84.8%) patients (Table 3). Hypokalemia was resolved in all
patients and no patient required potassium supplements
after surgery. Biochemical sign (ARR > 35) of PA was found
in four (8.9%) patients at a follow up of 6 months. Thepic single-site adrenalectomy in patients with primary hyper-
Asian Journal of Surgery (2015), http://dx.doi.org/10.1016/
Figure 1 Scatter plot (dash line) and learning curve (solid
line) of operative time.
Figure 3 Scatter plot (dash line) and cumulative curve (solid
line) of time to return to normal activity after LESS adrenal-
ectomy. LESS Z laparo-endoscopic single-site.
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+ MODELlaterality of all these four patients had been confirmed by
NP-59 SPECT/CT scan of AVS preoperatively. One of them
was confirmed to have idiopathic hyper-aldosteronism ac-
cording to the postoperative histological study.
4. Discussion
LESS adrenalectomy is one of the most promising LESS
procedures, because neither time consumingFigure 2 Scatter plot (dash line) and cumulative curve (solid
line) of time to oral intake after LESS adrenalectomy.
LESS Z laparo-endoscopic single-site.
Please cite this article in press as: Hu Y-H, et al., Laparoendosc
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j.asjsur.2015.09.002reconstruction nor further enlargement of the surgical
incision is required with a single small 2e3 cm incision for
LESS. Several preliminary and comparative studies revealed
its safety and feasibility in removing benign functional/
nonfunctional adrenal tumors.11,16e20 Among these early
series, APA and unilateral hyperplasia is the most common
indication for LESS adrenalectomy. However, most of these
early reports focus on perioperative outcomes and proce-
dure related complications. Only two comparative studies
mentioned their functional outcome of PA, and their
follow-up periods were either extremely short orTable 3 Surgical outcomes of LESS unilateral adrenalec-
tomy in patients with primary aldosteronism.
No. of patients (%)
Mean aldosterone:rennin
ratio (SD) ng/dL per ng/mL/h (SD)
Preoperative 169.66 (361.40)
Postoperative 18.48 (26.28)
Blood pressure control after
operation (%)
Normotensive without
medication (cure)
29 (63)
Normotensive with medication 10 (21.4)
Hypertensive 7 (15.6)
No. of hypokalemic patients (%)
Before operation 30 (61.2)
After operation (without
supplementation)
0 (0)
Data expressed as mean (SD) or absolute no. (%) of patients.
LESSZ laparo-endoscopic single-site; SDZ standard deviation.
opic single-site adrenalectomy in patients with primary hyper-
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Figure 4 Scatter plot and learning curve of morphine
dosage.
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comes in PA patients who underwent LESS adrenalectomy
were either scarce or inadequate. Although it is one of the
most common indications of LESS adrenalectomy, its func-
tional effectiveness in PA is still underdeveloped.
To the best of our knowledge, this is the first study
reporting the long-term functional outcomes of LESS adre-
nalectomy in PA patients. In our series, cure of hyperten-
sion was defined if blood pressure decreased to 140/
90 mmHg after adrenalectomy and patients were free from
antihypertensive medication within the 1st year of treat-
ment. The cure rate was as high as 63% in our long-term
follow up. This result is compatible with those open and
laparoscopic counterparts who have an overall cure rate of
60% with a compatible definition of “cure”.21 In addition,
our results revealed that blood pressure could be normal-
ized with antihypertensive medications in another 21% of
our PA patients (Table 3). Overall, 84% of our PA patients
had clinical improvement in blood pressure control after
their LESS adrenalectomy. In addition, preoperative hypo-
kalemia patients were all resolved in the early post-
operative phase. Therefore, the long-term effectiveness of
LESS adrenalectomy could be confirmed based on the cur-
rent study.
Several risk factors have been associated with potential
failure in blood pressure improvement following adrenal-
ectomy, including having one or more first-degree relatives
with hypertension, advanced age, duration of disease, and
lack of response to spironolactone.21e23 Additional factors
associated with persistence of hypertension were multiple
adenomas or nodular hyperplasia.24 In our series, we had
one case of unilateral hyperplasia who suffered aggravated
hypertension after adrenalectomy. The effectiveness of
adrenalectomy on PA patients due to unilateral hyperplasia
is still controversial.23,24 Walz et al24 found very late oc-
currences (5e14 years) of contralateral hyperplasia lesions
after unilateral adrenalectomy for unilateral hyperplasia. A
further cause of persistent or recurrent hypertension may
be the presence of preoperatively undetected bilateral
hyperplasia which could not be detected using the current
technology.22 Thus, for PA patients with functional later-
alized unilateral hyperplasia lesions, long-term or life-time
follow up is mandatory.
There are only two meta-analyses that compared LESS
and conventional laparoscopic adrenalectomy to date.14,15
These studies revealed compatible incidence of
procedure-related adverse events (complication, conver-
sion, and transfusion rate) between the two techniques.
The present cohort, which focused on PA patients under-
going LESS adrenalectomy, also revealed a compatible short
postoperative convalescence, minimal perioperative
complication, and low conversion rate (1 in 49 patients)
when compared with other LESS or conventional laparo-
scopic series. As we demonstrated in Figure 1, LESS adre-
nalectomy was associated with a short learning period in
experienced hands. What is interesting is that the transition
from one minimally invasive technique to the other also
demonstrated a short learning period with the patients’
convalescences rapidly and significantly shortening after
the learning period. In our logarithmic regression model
generated cumulative curve regarding patient’s convales-
cence, the regression curves revealed a progressivePlease cite this article in press as: Hu Y-H, et al., Laparoendosco
aldosteronism: A prospective study with long-term follow up,
j.asjsur.2015.09.002reduction of time to convalescence during all the progres-
sive cases. (Figures 2 and 3) Although LESS is commonly
associated with a long, steep learning curve, in experi-
enced hands, LESS adrenalectomy for PA is actually asso-
ciated with a short learning curve and also a short transition
period of longer patient convalescence.
LESS adrenalectomy is a recent novel approach; the
operative technique in LESS actually following the standard
protocol in conventional laparoscopic adrenalectomy. A
longer operative time was observed during the learning
period due to adaptation to a new approach. However, the
improvement in clinical outcome regarding hypertension
was not observed according to our data. In addition, during
LESS or conventional laparoscopic surgery, the lever pivot
point of the instrument is located at the trocar incision of
abdominal wall. The differences between LESS and lapa-
roscopy is, in our single-port design, the surgical incision
was only covered by a thin-layer soft transparent wound
protector and not a rigid plastic tube that we commonly use
in laparoscopy. Therefore, the blunt trauma associated
with the forces applied by instrument’s shaft was clearly
increased when the operative time was prolonged during
the learning curve. This phenomenon could be explained by
the increased postoperative analgesic usage during the
learning curve (Figure 4) Furthermore, analgesics (such as
morphine, demeral) usage after operation is one of the
main causes of delayed bowel movement and also the main
reason for delayed oral intake during the learning period.
What really amazed us is the two cases in our cohort who
suffered from persistent (longer than 6 months) erectile
dysfunction after their adrenalectomies, a phenomenon
never before reported in humans. Penile erection has been
mainly believed to be an androgen-associated process in
both rats and humans. Although blockage of nontesticular
origin androgen with antiandrogen has been shown to have
a negative impact on erection in castrated rats, the
androgen of adrenal origin plays a minor role in maintaining
erectile function in noncastrated mammals.25 In addition,
as penile erection is a nitric oxide dependent process in
intracellular mechanism, another possible explanation forpic single-site adrenalectomy in patients with primary hyper-
Asian Journal of Surgery (2015), http://dx.doi.org/10.1016/
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nalectomy might have a negative impact on nitric oxide
synthase (NOS) activity thus impairing the erectile function.
To date, only one study showed the adrenal gland con-
tributes to the maintenance of the erectile mechanism and
may affect neuronal NOS content in the penis in the rat
model.26 However, the evidence still remains scarce in
humans and the possibility that postadrenalectomy induced
hypotension also plays a role in erection could not be
totally ruled out. In short, erectile dysfunction is a possible
morbidity of adrenalectomy in PA patients, which deserves
further investigation in a large scale-study to confirm our
speculations.
In conclusion, this is the first and largest series of PA
patients treated with LESS adrenalectomy. Our experience
revealed that LESS adrenalectomy is a safe and effective
approach which is associated with comparable long-term
cure and improvement of hypertension compared with
conventional laparoscopic series in treating PA. In addition,
LESS adrenalectomy for PA is not only associated with a
short learning curve, but also a short transition period of
patient convalescence impairment in experienced hands.
Therefore, LESS adrenalectomy for PA is a suitable alter-
native for surgeons experienced in conventional laparo-
scopic adrenalectomy.
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